Harnessing the Power of Mouse Models to Decode COVID-19 Complexity

February 21, 2024

Featured image for “Harnessing the Power of Mouse Models to Decode COVID-19 Complexity”

As the COVID-19 pandemic caused by SARS-CoV-2 continues exerting a devastating global toll, intense R&D races to unravel the intricate biology underpinning this cagey virus and the cryptic disease it manifests. Among the multitude of research platforms enlisted in this urgent biomedical battle, mouse models have proven themselves indispensable allies. By enabling controlled in vivo interrogation of infection intricacies, they continue yielding vital insights that propel our collective understanding of COVID-19 forwards.

This article explores how mouse models are helping navigate the winding scientific odyssey to counter this formidable pandemic nemesis.

Why Study SARS-CoV-2 in Mice?

Mice have been a cornerstone preclinical model system facilitating biomedical advances for over a century owing to various advantages like:

  • Extensive molecular toolkits to precisely edit their genome
  • Breeding speed enabling large controlled experimental cohorts
  • Vast foundational literature mapping murine immunity
  • Similarity of mouse biology to many human physiological aspects

These capabilities have cemented mouse models as a preferred substrate for modeling infectious diseases and testing interventions against complex pathogens like influenza, malaria, HIV, tuberculosis, and hepatitis.

However, wild-type laboratory mice lack the specific human ACE2 receptor this novel coronavirus utilizes to infiltrate host cells. So mice remain impervious to SARS-CoV-2 encountered naturally. Scientists thus had to creatively transform mice into bespoke instruments capable of recapitulating aspects of COVID-19 pathology.

The payoffs for judiciously devising such customized mouse models are multidimensional, enabling unique investigations challenging or impossible to conduct directly in human patients or primate systems on ethical, logistical and financial grounds.

Artboard 1 copy 2 5

Bioengineering Mice Susceptible to SARS-CoV-2

Multiple creative molecular strategies have equipped mice with the crucial human ACE2 gateway to grant SARS-CoV-2 access for initiating replicative infection cycles afterexposure.

Transgenic Human ACE2 Mouse Lines

  • Pioneering work employed CRISPR editing to permanently incorporate synthetic human ACE2 genes at the homologous locus in mice to express the receptor in appropriate target cell populations.
  • Subsequently generated transgenic strains fine-tuned hACE2 expression patterns via lung-specific promoters to concentrate viral activity away from other sites.
  • More advanced current iterations activate hACE2 production only when desired using drug-triggerable genetic switches for tighter experimental control.

So transgenic hACE2 mouse lines have been important launchpads for seeding extensive foundations illuminating COVID’s convoluted biological terrain.

Viral Adaptation Strategies

In parallel, an alternate evolutionary tactic forcibly pressurizes SARS-CoV-2 to self-optimize its infectious grip directly in mice by serial lung-to-lung passaging until mutated variants with enhanced in vivo fitness and virulence emerge.

  • Landmark 2020 studies passed wild-type SARS-CoV-2 through ~25 generations of younger hACE2-transgenic mice exercising this forced adaptive evolution to generate a mouse-adapted strain with mutationally tweaked Spike protein for robust murine infection.
  • This virus variant afforded key headstarts in recapitulating facets of human disease like widespread pulmonary pathology and transmission between co-housed animals missing in early models.

So synergistically interweaving genetic edits in both host and pathogen has crucially equipped mouse models to reflect salient facets of COVID-19’s intricate biology.

Dissecting Disease Complexity in Infected Mouse Models

Armed with these enabling advances, researchers globally have extensively exploited mouse models as fertile sandboxes for probing the intricate immunological and tissue microenvironments hijacked by this virus.

Inflammatory Drivers of Pathology

  • Mouse infection experiments found SARS-CoV-2 inciting inflammation is central to disease severity, identifying key cytokine and leukocyte components underlying lung injury. This steers treatment possibilities.
  • Studies also tracked systemic impact on distant organs like heart and brain in infected mice, mirroring extra-pulmonary long COVID manifestations challenging survivors.

Testing Preventatives and Treatments

  • Mouse models have offered fertile testbeds for screening libraries of drug and antibody candidates inhibiting viral entry, replication and spread to identify promising options now in human trials.
  • They continue serving as critical platforms for appraising vaccines, judging protective capacities of emerging virus-specific immune responses.

Transmission and Emergent Variants

  • Mouse colonies enable monitoring viral mutations arising during transmission chains and gauging whether new variants exhibit heightened transmission or evasion of acquired immunity – facilitating variant risk surveillance.

So mouse models continue yielding vital insights on multiple research frontiers to push back against the pandemic.

Artboard 1 copy 8

Caveats and Limitations in Interpreting Mouse-Based Findings

However, important nuances are necessary when extrapolating insights from mouse modelling of SARS-CoV-2 to human contexts.

Severe Disease Manifestations Are Absent

No current mouse infected with SARS-CoV-2 strictly replicates the extensiveupper respiratory infection and life-threatening pneumonic histopathology prominent in the most severe human COVID-19 scenarios.

Immune Milieu Differs Between Species

Key species-specific differences in immune signaling pathways modulated during coronavirus infection likely sway downstream outcomes. Thus findings must be validated with in vitro human cell experiments.

Therapeutic Outcomes May Not Translate

Owing to the above complexities, candidate COVID countermeasures showing promising results in mouse tests may still fail to confer adequate protection in human patients.

So while mouse models offer unparalleled expediency in querying molecular mechanisms, appropriately tempering interpretations remains imperative.

Future Outlook: More Innovative Mouse Models Needed

Despite their nimbleness availing invaluable research inroads against the pandemic enemy, ever-crafty SARS-CoV-2 continues evolving – keeping model systems racing to catch up as new variants emerge.

Therefore, the long-term challenge mandates interdisciplinary big science collaborations between geneticists, immunologists, virologists and mammalian modelers to birth next-generation mouse systems tracking the protean pathogen’s shifts.

Fortunately, an array of promising ideas on the horizon could further enhance utility:

Breeding Multi-Susceptible Hybrid Mouse Lines

  • Merging transgenic hACE2 strains with mouse-adapted SARS-CoV-2 viruses by cross-breeding can unite their complementary strengths at prompting aspects of human-like disease not seen together previously.

Custom Simulations of Post-Vaccine Breakthrough Infections

  • Leveraging tunable gene switch technologies, researchers can model regimens mimicking vaccine protection waning and subsequent viral breakthroughs in mice reflecting real-world scenarios.

So there remain extensive opportunities for mouse systems to continue enriching our perspectives on this formidable foe, priming us with an integrated understanding of its weaknesses for devising enduring countermeasures to ultimately relinquish humanity from the pandemic’s crushing grip.

Addressing Key Questions Around Mouse Models of COVID-19

How accurately do current mouse models reflect severe human COVID-19?

No available mouse model fully recaptulates the extensive immune-mediated damage in lungs and vasculature underlying the most severe, potentially lethal human SARS-CoV-2 infections. However, they do mirror more moderate symptomatic illness and remain invaluable for molecular investigations despite limitations. Ongoing innovation is tailoring mice to more closely resemble facets of human disease.

What are key advantages mouse models offer over studies in human cell cultures alone?

Unlike cells in a dish, mouse models afford integral perspectives on how whole living systems dynamically interface with and respond to SARS-CoV-2 exposure over time. Mice allow assessing viral mutations, transmission between animals, clinical scoring and intricate tissue-specific effects in ways impossible solely using in vitro models derived from humans.

How helpful are mouse models for evaluating COVID-19 drugs versus vaccines?

Owing to their rapid breeding enabling statistically robust studies, ease of genetic manipulation, and prior record supporting translational advances, mouse models serve as frontline screening platforms for filtering vast libraries of potential antiviral drug and monoclonal antibody candidates. However, accurately evaluating longer-term specific protective capacities induced by next-generation COVID vaccines does remain challenging in mice alone given key immunological differences in some pathways.

What are key priorities for improving mouse models of COVID moving forwards?

Top priorities include engineering models manifesting more faithful pulmonary pathology via combined transgenic and adaptive approaches, developing models recapitulating heightened morbidity in aged mice, and breeding stocks mimicking chronic comorbidities like diabetes or coronary disease to mirror groups disproportionately impacted in human populations.

Could studying coronavirus relatives in mice yield insights against SARS-CoV-2?

Yes, investigating closely allied endemic beta-coronaviruses natively harboured by wild mice could reveal evolutionary lessons about adapting to host species, inform patterns of mutation, and pinpoint cross-reactive immune components protective against emergent relatives like SARS-CoV-2. This ecological foundation primes targeted ideas to test in labs using humanized mouse models of current concern.

In Summary…

  • Bioengineered mouse models enable controlled investigations of SARS-CoV-2 infection impossible in patients and essential for key advances.
  • They have already provided vital perspectives on COVID-19 disease mechanisms and allowed efficient preliminary testing of interventions.
  • Optimized next-generation mouse models incorporating accumulated insights represent a promising path to even more incisive understandings and countermeasure developments against further viral evolution.
  • Multidisciplinary collaborations embracing genetic innovations on both mouse and virus sides will enhance these systems’ future pandemic preparedness contributions.
  • Thus strategically embracing mouse models remains imperative for navigating the long voyage towards eventually conquering COVID-19.

So multifaceted murine systems will undoubtedly continue serving indispensable roles in this fraught pandemic era marked by profound biomedical uncertainties – rapidly decoding clues towards unraveling the remaining mysteries confounding humanity’s quest to decisively overcome this globe-encircling existential threat.

5/5 - (1 vote)

Related articles


Cold Plasma System

The world's first handheld cold plasma device

Learn More

Made in USA